Optometry & Vision Science:
Editor in Chief Optometry and Vision Science
I warned you that April 2014 would be a “first” for Optometry and Vision Science (OVS).
Well it is!
To my knowledge, OVS has never provided two full issues in the same month. In this case, it reflects the success of the journal and, in particular, the efforts to provide first-rate clinical publications in full color, along with video clips for our more clinically oriented readership. As I have noted in previous editorials, many of the clinical publications are most obviously enhanced by color and motion. This can only come without cost to our authors if we publish them online-only.
It is now 18 months since we began publishing our clinical communications in this format as a small part of each OVS issue. That seems to have been well received and is also the way most journals will publish within the next decade. This month, we celebrate that deliberate shift in direction with an entire issue on clinical publications in the online-only format. In short, it is a bonus issue for our members and our subscribers. The Academy has generously agreed to fund this bonus supplement, and we hope that this issue of OVS will be appreciated. (We have no other plans, in 2014, to do this again.) The articles in the bonus issue all underwent peer review and revisions in exactly the same way as the regular print issue articles do, and citation is also identical.
The editorial in the supplemental issue was cowritten by your editor and the OVS Clinical Editor (Larry J. Alexander), and it highlights another first with a lead article that we anticipate will provide a template for some of the very best of symposia presentations at our annual meeting. Take a look at that editorial and see what we are talking about.
Our regular April issue comes to you with the usual wide range of topics from studies that reveal the value of hard exudates as a surrogate for screening diabetic retinopathy for edema, even by remote imaging, to a range of studies that continue in the pursuit of the factors and treatments that accelerate or inhibit myopia development in children. We also learn from the Vision in Preschoolers (VIP) Study Group just how important stereoacuity can be as a signal for other vision problems in 3- to 5-year-olds, and the role of a controversial gene (PAX6 gene) in myopia development seems less controversial after our authors did a systematic review and meta-analysis of key publications.
Finally, we have two articles that relate to the optics of pseudophakic eyes and the impact on vision, along with a study suggesting that tear analysis might be useful in the general primary care setting. Further, we are told of the potential for using provocative glaucoma tests to identify relatives at high risk for angle closure glaucoma.
In short, the usual range of original research studies that you have come to expect in each monthly issue of OVS.
Editor in Chief
Optometry and Vision Science